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CLN1 disease (OMIM #256730) is an early childhood ceroid-lipofuscinosis associated
with mutated CLN1, whose product Palmitoyl-Protein Thioesterase 1 (PPT1) is a
lysosomal enzyme involved in the removal of palmitate residues from S-acylated
proteins. In neurons, PPT1 expression is also linked to synaptic compartments.
The aim of this study was to unravel molecular signatures connected to
CLN1. We utilized SH-SY5Y neuroblastoma cells overexpressing wild type CLN1
(SH-p.wtCLN1) and five selected CLN1 patients’ mutations. The cellular distribution
of wtPPT1 was consistent with regular processing of endogenous protein, partially
detected inside Lysosomal Associated Membrane Protein 2 (LAMP2) positive vesicles,
while the mutants displayed more diffuse cytoplasmic pattern. Transcriptomic
profiling revealed 802 differentially expressed genes (DEGs) in SH-p.wtCLN1 (as
compared to empty-vector transfected cells), whereas the number of DEGs
detected in the two mutants (p.L222P and p.M57Nfs∗45) was significantly lower.
Bioinformatic scrutiny linked DEGs with neurite formation and neuronal transmission.
Specifically, neuritogenesis and proliferation of neuronal processes were predicted
to be hampered in the wtCLN1 overexpressing cell line, and these findings
were corroborated by morphological investigations. Palmitoylation survey identified
Abbreviations: B-H p-value, Benjamini and Hochberg corrected p-value; CRMP1, Collapsin Response Mediator Protein
1; CTSD, Cathepsin D; DAPI, 4′,6-diamidino-2-phenylindole dihydrochloride; db-cAMP, Dibutyryl-cyclic AMP; DEG,
Differentially Expressed Gene; DNAJC5, DnaJ Heat Shock Protein Family (Hsp40) Member C5; EA, Enzymatic Activity;
EEG, Electroencephalogram; FE, Fold Enrichment; FDR, False Discovery Rate; FPKM, Fragments Per Kilobase per Million
mapped reads; GAP43, Neuromodulin or Growth Associated Protein 43; IF, Immunofluorescence; IPA, QIAGEN’s Ingenuity
Pathway Analysisr; LAMP2, Lysosomal Associated Membrane Protein 2; log2FC, Log2 fold change; LSD, Lysosomal
Storage Disease; NCL, Neuronal Ceroid Lipofuscinosis; NFs, Neurofilament Proteins; PANTHER, Protein ANalysis
THrough Evolutionary Relationships; PATs, Palmitoyl-Acyl Transferases; PPT1, Palmitoyl-Protein Thioesterase 1; qPCR,
quantitative real-time PCR; RA, all-trans Retinoic Acid; RA-NBM, all-trans Retinoic Acid—Neurobasal medium; rhBDNF,
recombinant human Brain-Derived Neurotrophic Factor; SEMA3A, Semaphorin 3A; SNAP25, Synaptosome Associated
Protein 25; WB, Western blotting; zDHHC, Zinc finger S-acyl transferases.
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113 palmitoylated protein-encoding genes in SH-p.wtCLN1, including 25 ones
simultaneously assigned to axonal growth and synaptic compartments. A remarkable
decrease in the expression of palmitoylated proteins, functionally related to axonal
elongation (GAP43, CRMP1 and NEFM) and of the synaptic marker SNAP25, specifically
in SH-p.wtCLN1 cells was confirmed by immunoblotting. Subsequent, bioinformatic
network survey of DEGs assigned to the synaptic annotations linked 81 DEGs, including
23 ones encoding for palmitoylated proteins. Results obtained in this experimental
setting outlined two affected functional modules (connected to the axonal and synaptic
compartments), which can be associated with an altered gene dosage of wtCLN1.
Moreover, these modules were interrelated with the pathological effects associated with
loss of PPT1 function, similarly as observed in the Ppt1 knockout mice and patients with
CLN1 disease.
Keywords: CLN1 disease, PPT1, differentiated neuroblastoma cells, RNA-seq, neuritogenesis, dysregulated
genes, palmitoylation
INTRODUCTION
Neuronal ceroid lipofuscinoses (NCL) are a group of lysosomal
storage diseases (LSD) mainly affecting brain and retina (Mole
et al., 2011). NCL are named after the unifying pathological
hallmark, i.e., the accumulation of autofluorescent lipopigments
with characteristic ultrastructural features in the cytoplasm
of neurons and other cell types (Goebel et al., 1974; Haltia,
2003). Thirteen NCL genes have been identified so far and an
equivalent number of NCL forms are currently considered in
NCL nosography1. Five NCL genes encode lysosomal proteins,
whereas the remaining gene products localize to other cell
compartments. A definitive function has been established for
a number of proteins only (Cárcel-Trullols et al., 2015).
CLN1 disease (OMIM #256730) refers to a NCL form associated
with a childhood onset phenotype (Santavuori et al., 1974; Vesa
et al., 1995; Simonati et al., 2009), and a rare adult onset
one (van Diggelen et al., 2001). Common biomarker of both
phenotypes is the reduced enzyme activity (EA) of Palmitoyl-
Protein Thioesterase 1 (PPT1), the gene product of CLN1, whose
mutations are disease-related.
PPT1 is a palmitoyl-thioesterase highly expressed in neuronal
cells. It is a soluble, hydrolytic lysosomal enzyme, involved in the
degradation of S-acylated proteins by removing the palmitate
residues (Hellsten et al., 1996; Verkruyse and Hofmann, 1996;
Bellizzi et al., 2000). In neurons, it is also localized in other
cellular compartments (such as axons and specialized neural
endings) where its enzymatic activity is conveyed at neutral
pH (Cho et al., 2000b; Shyng et al., 2017). This localization
as well as the fact that its expression is developmentally
regulated in both humans and mice is consistent with a neuron-
specific function for PPT1 (Isosomppi et al., 1999; Heinonen
et al., 2000). Several lines of evidences indicate that in nerve
terminals PPT1 is involved in regulation of exo/endocytosis,
synaptic vesicle recycling and eventually neurotransmission
(Kim et al., 2008; Aby et al., 2013). Palmitoylation, the lipidic
post-translational modification in which PPT1 is involved,
1http://www.ucl.ac.uk/ncl/mutation.shtml
regulates intracellular trafficking and shuttling of proteins
among different membrane organelles, particularly in neuronal
cells (Fukata and Fukata, 2010). Therefore, it is not surprising
that several human disorders affecting neural functions,
including schizophrenia, Huntington’s and CLN1 diseases are
associated with defective palmitoylation (Hornemann, 2015).
Although more than 20 enzymes promoting palmitoylation
(Palmitoyl-Acyl Transferases, PATs, also known as zinc
finger S-acyl transferases, zDHHC) are recognized, only
three de-palmitoylating enzymes including PPT1 have been
thus far identified (Fukata and Fukata, 2010; Blanc et al.,
2015).
Both in vivo models (including zebrafish and mice) and
in vitro systems have been extensively used to dissect out
the role of PPT1 in neuronal tissues (Lyly et al., 2007;
Bond et al., 2013; Faller et al., 2015). Among cellular
models, neuroblastoma cells have been acknowledged as
a useful system to investigate the effects of NCL genes
expression on neuronal functions and protein interactions.
Overexpression of CLN1 protects LAN-5 neuroblastoma cells
from ceramide-induced apoptosis (Cho and Dawson, 2000),
whereas antisense treatment (leading to a reduced expression
of PPT1) increased the susceptibility to undergo cell death
(Cho et al., 2000a). Recently, SH-SY5Y neuroblastoma cells
overexpressing either CLN1, CLN3 or CLN5 have been also
used to recognize putative interacting proteins of PPT1 and
CLN3/CLN5 crosstalk by proteomics approach (Scifo et al., 2013,
2015a,b).
The aim of this study was to recognize molecular signatures
and functional modules connected with overexpressed CLN1
in human neuronal cellular system. We utilized SH-SY5Y
neuroblastoma cells (differentiated into a neuronal-like
phenotype, Pezzini et al., 2017) to overexpress wtCLN1 and
a selection of disease related mutations previously detected in
CLN1-affected children. The differentiated cell lines underwent
whole transcriptomic profiling by RNA-seq, to identify
differentially expressed genes (DEGs) which are functionally
related to the overexpression of wild-type or mutated PPT1.
Following bioinformatic investigations, we focused on DEGs
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involved in palmitoylation of neuronal proteins as well as related
cellular functions. Interestingly, genes coding for palmitoylated
proteins assigned to neuronal functions, such as axonal growth,
and to the synaptic compartment were the most significantly
expressed. Moreover, to identify potential therapeutic targets
for CLN1 disease, we aimed to demonstrate possible links
with other NCL genes, particularly CLN4 and CLN10, sharing
common pathological traits with PPT1 (Haltia and Goebel,
2013).
MATERIALS AND METHODS
Cell Culture
Human neuroblastoma SH-SY5Y cells (catalog number
#94030304 European Collection of Cell Cultures) were cultured
in DMEM-High glucose medium supplemented with 15%
Foetal Bovine Serum (FBS), 2 mM L-glutamine and 1%
non-essential amino acids (all from Euroclone), at 37◦C in
humified atmosphere with 5% CO2, as described (Pezzini et al.,
2017).
Production of PPT1 Constructs, Cell
Transfection and Generation of Stable Cell
Lines
We focused our attention on CLN1 mutations described
in Mediterranean patients affected by classical and variant
CLN1 disease. Specifically, we selected three different
missense mutations (c.665T>C/p.L222P, c.541G>A/p.V181M
and c.541G>T/p.V181L), a deletion of the second exon
(c.125_235del/p.G42_E78del) in which the ORF is maintained
and a one-base insertion (c.169dupA/p.M57Nfs∗45) predicting
a frameshift, and a premature stop codon at residue 101
(Santorelli et al., 1998). Wild-type and mutated CLN1 cDNAs
(NM_000310) were inserted into pcDNA3 expression vector
(Invitrogen, Life Technologies [LT]) by PCR methods. The
sequences of CLN1 constructs were confirmed by direct
sequencing using BigDye Terminator v3.1 Cycle Sequencing
Kit (Applied Biosystems, LT), on an ABI3130xl automatic DNA
Analyzer. SH-SY5Y cells were plated 1 day before transfection
at 80% confluence in 35 mm dishes, and then transfected with
250 ng of cDNAs per dish using lipofectamine method (Applied
Biosystems, LT) following the manufacturer’s instructions.
Clones which stably overexpressed the different CLN1 cDNAs
were finally isolated through antibiotic selection with 600 µg/ml
geneticin (G418, Gibco, LT). Cells overexpressing the empty
TABLE 1 | The compendium of CLN1 overexpressing SH-SY5Y neuroblastoma
cell lines used in the study.
Cell line Transfected CLN1 cDNA Effect on PPT1 protein
SH-SY5Y - -
SH-pcDNA3 pcDNA3 (Empty Vector) -
SH-p.wtCLN1 wtCLN1 -
SH-p.L222P c.665T>C p.L222P
SH-p.V181L c.541G>A p.V181L
SH-p.V181M c.541G>T p.V181M
SH-p.M57Nfs∗45 c.169dupA p.M57Nfs∗45
SH-p.G42_E78del c.125+15T>G p.G42_E78del
pcDNA3 vector (hereafter also referred as mock) served as a
control (Table 1).
Quantitative Real-Time RT-PCR Analysis
Total cellular RNA was extracted from neuroblastoma cells
using the Tri Reagent (Sigma-Aldrich) following manufacturer’s
instructions. The reverse transcription was performed by
High-Capacity cDNA Reverse Transcription kit (Applied
Biosystems, LT) and 1.5 µg of cDNAs were amplified in
an ABI 7500 Fast real time PCR. The expression of CLN1
was assessed by qPCR using inventoried Taqman assay
(Hs00165579_m1; Applied Biosystems, LT), and normalized to
the level of GAPDH (Hs99999905_m1) using the comparative Ct
method.
Neuronal Differentiation Paradigm
Parental SH-SY5Y cells and transfected cells were analyzed both
under basal conditions and following neuronal differentiation in
all-trans Retinoic Acid-Neurobasal medium (RA-NBM)medium
(Pezzini et al., 2017). In brief, cells were pre-differentiated
in DMEM/HIGH supplemented with 5% FBS and 10 µM
RA (Sigma-Aldrich) for 6 days, and then grown for further
3 days in Neurobasal medium (GIBCO, LT) enriched with
50 ng/ml recombinant human BDNF (rhBDNF, Peprotech),
2 mMDibutyryl-cyclic AMP (db-cAMP; Sigma-Aldrich), 20 mM
KCl, B27 supplement and 1% GlutaMAX (GIBCO, LT). Control
(not treated, NT) cells were cultured in parallel under basal
conditions at the same FBS concentration (5%). Cells were
seeded in T75 flasks or on coverslips coated with ECMax
gel (Sigma-Aldrich) at the same density of 8 × 103 cells
per cm2, grown for 24–48 h and then exposed to RA-NBM
treatment. Media were routinely changed every 2–3 days;
the morphological features of control and CLN1 transfected
cell lines were monitored under an Axio Vert.A1 inverted
microscope (Zeiss). The images were acquired by True Chrome
HD II cam system. Cells grown under basal conditions
were harvested after 6 days to avoid the culture over-
growth.
Immunofluorescence Microscopy
Following fixation in 4% paraformaldehyde, coverslips
were rinsed in PBS and incubated in blocking solution
and then probed overnight at 4◦C with primary antibodies
diluted in incubation buffer. Primary antibodies used for
immunofluorescence (IF) assay were as follows: rabbit polyclonal
anti-PPT1 (1:50, Cat# HPA021546, Sigma Aldrich), which
recognized a C-terminal region (aa 223-306), mouse monoclonal
anti-LAMP2 (1:400, H4B4 clone, Cat# ab25631, Abcam),
mouse monoclonal SMI31R (specific for phosphorylated heavy
chain neurofilament; 1:200, Cat# SMI31R, Covance), rabbit
monoclonal anti-βIII tubulin (1:200, clone EP1569Y, Cat#
04-1049, Merck Millipore). Goat anti-mouse and anti-rabbit
conjugated with AlexaFluor 488 or AlexaFluor 594 dyes (1:800,
Cat# A11005 and A11008 respectively, Molecular Probes, LT)
were used as secondary antibodies for 1 h at RT. Finally, nuclei
were counterstained with 5 µg/ml DAPI (4′,6-diamidino-
2-phenylindole dihydrochloride, Sigma-Aldrich). Images
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were acquired by an AxioLab microscope equipped with an
AxioCam and AxioVision 4.3 software (Zeiss). In addition,
confocal microscopy analyses following LAMP2/PPT1 staining
was performed on a Zeiss LSM 710 (laser argon 488 nm
and HeNe 543 nm) using 40× Plan NeoFluar 0.75 and
63× 1.4 NA Plan Apochromat oil-immersion lenses; images
were acquired by Zeiss LSM 710 software and analyzed by
ZEN Lite 2012 (Zeiss). Colocalization analysis of PPT1 and
LAMP2 immunostainings was performed on SH-p.wtCLN1 cell
line by Anima image analysis software (Rantanen et al.,
2014).
The density of β-III tubulin immunolabeled neurites was
evaluated by NeuronJ plugin of ImageJ as described elsewhere
(Supplementary Methods in Supplementary Material and
Pezzini et al., 2017). In brief, following images acquisition
at 10× magnification, NeuronJ plugin was used to manually
trace neurites; only processes longer than 30 µm were taken
into account. The number of neurites was normalized on
the cellular density by counting nuclei stained by DAPI.
At least 1500 cells from three independent experiments
were analyzed and data were reported as mean ± SEM;
statistical significance was assessed by one-way ANOVA
followed by Bonferroni post-test on SH-pcDNA3 cell
line.
Western Blotting Analysis
Cellular pellets were homogenized in RIPA buffer containing
inhibitors of proteases (Roche Diagnostics GmbH), resolved
by electrophoresis in SDS-polyacrylamide gels (or alternatively
in NuPAGE Novex 4–12% Bis-Tris protein gels, LT) under
denaturing conditions and finally transferred to PVDF
membranes (Bio-Rad Laboratories). Primary antibodies
used for Western Blotting (WB) are listed below: rabbit
polyclonal anti-PPT1 (1:1000, Cat# HPA021546, Sigma Aldrich),
mouse monoclonal anti-neurofilament 160/200 (1:500, Clone
RMdO20, Cat# N2912, Sigma Aldrich), rabbit polyclonal
anti-CRMP1 (1:2000, Cat# C2868, Sigma-Aldrich), rabbit
polyclonal anti-GAP43 (1:2000, Cat# AB5220, Chemicon,
Merck Millipore), rabbit polyclonal anti-SNAP25 (1:10,000,
Cat# S9684, Sigma-Aldrich), rabbit polyclonal β-III tubulin
(1:1000, Cat# CSB-PA03874A0Rb, Cusabio). Immunodetection
with anti-GAPDH (1:30,000, Cat# G9545, Sigma-Aldrich)
was used as loading control. Species-specific HRP conjugated
antibodies (anti-mouse and anti-rabbit IgG HRP linked
f(ab’)2 fragment, 1:10,000, Cat# GEHNA93101ML and
GEHNA93401ML, Amersham GE Healthcare) were used
as secondary antibodies. Chemiluminescent detection was
performed with Immobilon Western Chemiluminescent HRP
Substrate (Merck Millipore) according to manufacturer’s
instructions. For quantitative evaluation, protein lysates from
at least three independent experiments were assessed in the
same electrophoretic run. For densitometry analysis, the
optical density (OD) of each band was assessed by ImageJ
software and normalized to OD of a loading control (GAPDH).
Data were reported as mean ± SEM. Statistical analyses
were carried out using either unpaired t-test analysis or
ANOVA followed by Bonferroni post hoc test, considering
as significant a p value < 0.05 and as highly significant a
p value< 0.01.
PPT1 Enzyme Activity Assay
PPT1 EA was assessed by monitoring fluorescence release of
4-methylumbelliferone in a LS-50B Perkin–Elmer fluorometer,
as previously described (Bonsignore et al., 2006).
Whole Transcriptomic Analysis by
RNA-seq
The whole transcriptomic analysis was carried out on CLN1
transfected SH-SY5Y cells following RA-NBM treatment.
Specifically, we investigated the wtCLN1 overexpressing cell
line (SH-p.wtCLN1) and two cell lines carrying either a
missense mutation (SH-p.L222P) or a mutation leading to
premature protein truncation (SH-p.M57Nfs∗45); empty-
vector transfected cells (mock) and parental SH-SY5Y
cells were also analyzed as a reference. RNA samples were
collected in three independent experiments by TRI Reagent
(LT) and checked for purity (by Nanodrop 1000, Agilent
Technologies), and integrity (RNA Integrity Number ≥8.0).
Indexed cDNA libraries’ preparation, sequencing by Illumina
HiSeq 1000 sequencer and alignment of reads to reference
human genome (hg19) were performed as previously reported
(Pezzini et al., 2017). To allow the comparison of gene
expression profiles, the normalized expression values for
each transcript were calculated as Fragments Per Kilobase
per Million mapped reads (FPKM). The expression profile of
each CLN1 transfected cell line (SH-p.wtCLN1, SH-p.L222P
and SH-p.M57Nfs∗45) was then compared to the profile
of mock cells: for each gene the ratio between average
FPKM of each cell line and average FPKM of mock cells
was calculated and reported as log2 fold change (log2FC).
Transcripts showing a |log2(FC)| ≥1 and a False Discovery
Rate (FDR, q-value) ≤0.05 were assigned as differentially
expressed.
Bioinformatic Analysis and Categorization
of Transcriptomic Data
Sets of differentially expressed genes (DEGs, corresponding to
identified transcripts) of each CLN1 transfected cell line, were
evaluated by QIAGEN’s Ingenuityr Pathway Analysis (IPAr,
Winter release 2017, QIAGEN2), to recognize meaningful
biological processes and molecular pathways. Specifically, we
carried out a Core Analysis followed by Downstream Effects
Analysis; Ingenuity Pathway Analysis (IPA) macro-categories
of Molecular and Cellular Functions and Physiological System
Development and Function were further scrutinized. P-value,
which was ascertained by right-tailed Fisher’s Exact Test
following Benjamini and Hochberg (B-H) correction, indicated
the robustness of correlation between a subset of DEGs of
the dataset with a given biological function. Moreover, IPA
algorithm calculated a ‘‘z-score’’ which estimates a predicted
activation or inhibition of a given biological function. In
2www.qiagen.com/ingenuity
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FIGURE 1 | Characterization of CLN1 mRNA and corresponding Palmitoyl-Protein Thioesterase 1 (PPT1) protein expression in CLN1 transfected cells. (A) qRT-PCR
quantitation of mRNA expression in transfected CLN1 cells. All transfected cells showed an increased expression of CLN1 mRNA ranging from 5 to 15 fold change in
comparison to the endogenous level in controls (both parental and empty vector pcDNA3, mock-transfected cells). Mean ± SEM of three independent experiments;
One-way ANOVA followed by Bonferroni’s multiple comparison test; ∗∗∗p < 0.001. (B) Double immunofluorescence (IF) assay for PPT1 (green) and the lysosomal
marker LAMP2 (red) revealed a strong signal of PPT1 in cells which stably expressed either wtCLN1 (b and c) or two different missense mutations (p.L222P, e and f;
p.V181L, h and i). Empty vector expressing cells (a), the CLN1 insertion (p.M57Nfs∗45, d) and the CLN1 deletion (p.G42_E78del, g) are shown in comparison. A
partial localization inside lysosomes was observed for SH-p.wtCLN1 (inset in c), whereas a more diffuse cytoplasmic pattern was detected for SH-p.L222P and
SH-p.V181L (f and i). Nuclei are marked by white asterisks; scale bars equal to 20 µm (h) and 10 µm for insets (c, f and i). Colocalization is shown in yellow.
(C) Overexpression of PPT1 in both SH-p.wtCLN1 cells and cell lines harboring a missense mutation was confirmed by immunoblotting analysis. The 38–36 kDa
doublets were detected in homogenates of wtCLN1 cells. A different pattern was associated with the missense mutation-bearing proteoforms of PPT1- a single
band, running approximately at 41 kDa, was detected in homogenates of these CLN1 mutants only. In cells transfected with indel mutations, the 38–36 kDa
doublets could be identified following high exposure only, suggestive for a representation of the endogenous PPT1 signal. NT, non-treated; all-trans Retinoic
Acid-Neurobasal medium (RA-NBM), differentiated cells. (D) Strong increase in PPT1 enzymatic activity (EA) was observed in SH-p.wtCLN1 as compared to
SH-pcDNA3 empty vector cells (3-fold change). Parental SH-SY5Y and cell lines carrying different mutations demonstrated some variability in PPT1 EA, with less
than 0.25 fold change in relation to the empty vector transfected cell line. Mean ± SEM of three independent experiments; One-way ANOVA followed by Bonferroni’s
multiple comparison test; ∗∗∗p < 0.001.
particular, to compare the three independent Core Analyses of
SH-p.wtCLN1, SH-p.L222P and SH-p.M57Nfs∗45, we selected
the most meaningful functional annotations (p-value < 0.05)
assigned to each CLN1 transfected cell lines. Subsequently,
only annotations demonstrating a |z-score| >0.5 in at least
one cell line were taken into account for the heat-map
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representation. Furthermore, selected subsets of DEGs were
also queried through PANTHER database (Protein ANalysis
THrough Evolutionary Relationships, Mi et al., 2017)3 to
elucidate the association with (GO) terms/attributes. Cytoscape
software (version 3.4.0, Cline et al., 2007)4 with GeneMANIA
Cytoscape plugin (Montojo et al., 2010) were utilized to draw
networks.
Identification of Differentially Expressed
Genes Encoding for Palmitoylated Proteins
Datasets of DEGs from each CLN1 expressing cell line were
subsequently queried for genes encoding the palmitoylated
proteins. Specifically, we inquired SwissPalm—Protein
Palmitoylation database (Blanc et al., 2015)5 from which
both evidence-based and predicted palmitoylated proteins were
retrieved. In addition, we used the curated compendium of
mammalian palmitoylome reported by Sanders et al. (2015),
and containing 1838 candidate proteins identified by screening
of 15 palmitoylation-related proteomic publications. Several
DEGs encoding palmitoylated proteins, and assigned to
relevant IPA biological functions were further investigated by
semi-quantitative WB.
Data Availability
RNA-seq data discussed in this publication have been deposited
in NCBI’s Gene Expression Omnibus and are accessible through
GEO Series accession number GSE988346.
RESULTS
Characterization of CLN1 Transfected
SH-SY5Y Cells
To assess the overall efficacy of CLN1 transfection, we
investigated the expression of CLN1 by quantitative real-time
PCR (qPCR) performed on RNA samples derived from
different neuroblastoma clones. CLN1 mRNA overexpression
ranged from 5 to 15- fold change as compared to basic
expression in parental SH-SY5Y line and empty vector
(pcDNA3) transfected cells. CLN1 mRNA overexpression
was significantly high in three generated cell lines,
namely SH-p.wtCLN1, SH-p.L222P, SH-p.M57Nfs∗45
(Figure 1A).
The expression of PPT1 was subsequently characterized by IF,
WB and EA. Following IF, both parental and mock-transfected
SH-SY5Y cells demonstrated a faint cytoplasmic dot-like
staining (Figure 1B). A clear dot-like pattern was associated
with the overexpression of wtPPT1, which partially colocalized
with LAMP2 lysosomal staining (Overlap coefficient equal to
0.59, in accordance with other wtPPT1 cellular models; Scifo
et al., 2015a,b); in addition, wtPPT1 was partially detected
3http://pantherdb.org
4http://www.cytoscape.org/
5http://swisspalm.epfl.ch/
6https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?token=srihcgwahfevtcd&acc=GSE98834
inside LAMP2 positive vesicles (inset c in Figure 1B).
Conversely, a more diffuse, cytoplasmic pattern associated
with a reduced PPT1 localization in LAMP2-immunolabeled
vesicles was observed in cells carrying missense mutations.
Colocalization analysis confirmed the qualitative findings
and showed lower Overlap coefficients of missense mutated
PPT1 with the lysosomal staining as compared to the
wtPPT1 (Supplementary Figure S1). Cells transfected with
cDNA harboring either the deletion (SH-p.G42_E78del)
or the single base insertion (SH-p.M57Nfs∗45) showed a
faint IF, as detected in parental and mock-transfected cells
(Figure 1B).
WB revealed differences in the patterns of expression of PPT1.
In the lysates of parental and mock-transfected cells, anti-human
PPT1 antibody recognized three bands running approximately
at 43, 38 and 36 kDa (Figure 1C). The 38–36 kDa doublet
likely represented mono- and di-glycosylated isoforms of mature
PPT1, as previously described in neuronal cells (Lyly et al.,
2007; Scifo et al., 2015a), whereas the ∼43 kDa band—present
to a similar extent in all the analyzed cell lysates—may denote
an uncharacterized form of PPT1 specific for SH-SY5Y cells
(Scifo et al., 2015a). SH-p.wtCLN1 demonstrated a remarkable
increase in the expression of the 38–36 kDa doublet whereas
the 43 kDa band remained unchanged. Upon treatment
with PNGase, performed to remove glycosylated chains, an
apparent shift of about 4 kDa in mass resulted in a single
PPT1-immunoreactive band in SH-p.wtCLN1 (Supplementary
Figure S2).
Cell lines harboring missense mutations displayed highly
intense signal of PPT1 protein, but the electrophoretic mobility
pattern was clearly different in comparison to wtCLN1;
a new band migrating approximately at 41 kDa was the
most intense whereas the 38–36 kDa doublet was weaker.
Deglycosylation following PNGase treatment resulted in a single
band, shifted approximately by 1–2 kDa, in p.L222P and
p.V181L (Supplementary Figure S2). The weak 38–36 kDa
doublets, consistent with the expression of endogenous PPT1,
were detectable in the indel clones (SH-p.G42_E78del and
SH-p.M57Nfs∗45).
Furthermore, we checked whether the overexpressed
PPT1 forms retained the enzymatic activity. Mock cells showed
a slight increase (∼40%) in PPT1 activity as compared to
parental SH-SY5Y cells. On the contrary, cells overexpressing
wtCLN1 exhibited a 3-fold higher enzymatic activity, in
relation to mock-transfected SH-SY5Y cells. Activities measured
in other CLN1 cell lines showed values ranging between
parental and SH-pcDNA3 values, suggesting that only the
endogenous activity of PPT1 was retained in these cells
(Figure 1D).
The neuronal differentiation paradigm in RA-NBM media
was effective in all analyzed cell lines, as reported for
the parental SH-SY5Y neuroblastoma cells (Pezzini et al.,
2017). Changes in shape of neuronal cell bodies and a
significant elongation of their main processes have occurred
(Supplementary Figure S3A), followed by alterations in the
expression of SEM3A, a protein related to the induction of
neuronal differentiation (conversion to a lower 65 kDa isoform,
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Supplementary Figure S3B). The expression of PPT1 was not
affected by differentiation in RA-NBM media (Supplementary
Figure S3C).
Comparative Analysis of Gene Expression
Profiles
We generated a transcriptomic profile of three CLN1 transfected
cells as compared to empty-vector pcDNA3 expressing cells.
We chose three cell lines (SH-p.wtCLN1, SH-p.L222P, SH-
p.M57Nfs∗45), which expressed the highest amount of CLN1
mRNA upon transfection (Figure 1A). The transcriptomic
profiles revealed 802 transcripts differentially expressed in
SH-p.wtCLN1 cells (of which 286 were up-regulated and
516 down-regulated, Supplementary Table S1). The number
of differentially expressed transcripts identified in the two
mutated clones was significantly lower (212 for SH-p.L222P,
50 up- and 162 down-regulated, Supplementary Table S2;
211 for SH-p.M57Nfs∗45, 54 up- and 157 down-regulated,
Supplementary Table S3). 629 transcripts were specifically
dysregulated in cells overexpressing the wild-type form of PPT1
(Figure 2).
Bioinformatic Examination of Differentially
Expressed Genes
Categorization through the bioinformatic suite IPA of
DEGs identified in SH-p.wtCLN1 demonstrated Cellular
Development, Cell-to-Cell Signalling and Interaction and Cell
Morphology as the most meaningful Molecular and Cellular
Functions categories. Moreover, Nervous System Development
and Function was among the three high-ranked categories
related to the Physiological System Development and Function,
suggesting an alteration of neurobiological processes in these
cells (Figure 3A). Likewise, the same IPA categories were
significantly annotated in the two mutants (Figures 3B,C).
SH-p.wtCLN1 cells displayed a higher number of DEGs which
were assigned to each IPA category. Further scrutiny of the
four main categories in SH-p.wtCLN1 profile pinpointed
functional annotations related to changes of neuronal cell
shape and formation of neurites (neuritogenesis; growth,
branching and morphogenesis of neurites; axonogenesis) as
well as neuronal differentiation (differentiation of neurons,
development of neurons; Figure 3D). Taking into account the
z-scores, most of these annotations were severely affected
FIGURE 2 | Transcriptomic analysis of CLN1 transfected cell lines. (A) Venn diagram demonstrating the amount of differentially expressed genes, identified in
SH-p.wtCLN1 cells (n = 802) and in the two mutated CLN1-transfected cell lines (n = 212, SH-p.L222P and n = 211, SH-p.M57Nfs∗45). Notably, 629 differentially
expressed genes (DEGs) were exclusively expressed in the SH-p.wtCLN1 clone. Differential gene expression analysis was performed on RA-NBM differentiated cell
lines and compared to the empty vector expressing cells (SH-pcDNA3), analyzed under the same culture conditions. (B–D) Scatter plot representation of differentially
expressed genes identified in differentiated SH-p.wtCLN1 (B), SH-p.L222P (C) and SH-p.M57Nfs∗45 (D) cells. Gene expression levels are reported as log2(FPKM)
(y axis) and compared to differentiated SH-pcDNA3 cells (x axis). Colored dots represent differentially expressed genes (thresholds: |log2FC| > 1 and
q-value < 0.05), which are either up-regulated (red dots) or down-regulated (green dots).
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FIGURE 3 | Bioinformatic survey of identified differentially expressed genes in wild-type and mutated CLN1 cell lines. (A–C) Categorization by Ingenuity Pathway
Analysis (IPA, Qiagen) of DEGs in differentiated SH-SY5Y cells. Molecular and Cellular Functions as well as Physiological System Development and Functions IPA
classes were examined. Categories of Cellular Development, Cell-to-Cell Signalling and Interaction, Cell Morphology as well as Nervous System Development and
Function with lowest B-H corrected p-values were further scrutinized. The number of genes assigned to each category is reported. Statistical significance is reported
as –log10 of Benjamini-Hochberg corrected p-value. (D) Heat-map representation depicted most meaningful IPA functional annotations enclosed in Cellular
Development, Cell-to-Cell Signalling and Interaction, Cell Morphology and Nervous System Development and Function. Cellular functions correlating with
morphological changes of neuronal cells (neuritogenesis, growth/branching/ morphogenesis of neurites and axonogenesis) and neuronal commitment (differentiation
of neurons, development of neurons) were commonly affected in SH-p.wtCLN1 and, to a lesser extent, in the two mutated cell lines, following a gradient according
to z-scores (from highest to lowest). Functions related to neuronal transmission (long-term potentiation, secretion of neurotransmitter and neurotransmission) were
also annotated. Notably, other annotations related to sprouting of neuronal processes (dendritic growth/branching, shape change of neurites, shape
change/branching of neurons, guidance of axons) as well as synaptic transmission (developmental process of synapse, long-term potentiation of synapse, plasticity
of synapse, release of neurotransmitter and action potential of cells) were selectively assigned to SH-p.wtCLN1 cells only. Functional annotations, shared among the
IPA classes are marked by dots. Colored squares represent either a predicted activation (red) or a predicted inhibition (green) according to z-score calculated by IPA
algorithm; higher color intensity correlates with more significant bioinformatic prediction.
in SH-p.wtCLN1 and predicted to be inhibited; a similar
trend was seen for SH-p.L222P (even though the number of
annotated functions was lower than wtCLN1 clone), whereas
bioinformatic predictions for SH-p.M57Nfs∗45 were less
pronounced. Functions related to neuronal transmission
(such as long-term potentiation, secretion of neurotransmitter
and neurotransmission) were also annotated. Additional
IPA attributes referred to sprouting of neuronal processes
(dendritic growth/branching, shape change of neurites, shape
change/branching of neurons, guidance of axons) as well as
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synaptic transmission (developmental process of synapse, long-
term potentiation of synapse, plasticity of synapse, release of
neurotransmitter and action potential of cells) were selectively
assigned to SH-p.wtCLN1 cells (lower part of the Figure 3D).
Notably, both the relative high number of annotations and
associated z-scores indicated that these functions were
remarkably affected in SH-p.wtCLN1 as compared to other
analyzed cell lines.
Palmitoylation Gene/Protein Survey
Taking into account the process of palmitoylation in which
CLN1/PPT1 is involved, we further scrutinized DEGs identified
in the three CLN1 transfected cell lines to seek for genes which
are known to encode palmitoylated proteins. Survey of the
mammalian palmitoylome derived from Blanc et al. (2015) and
Sanders et al. (2015) in SH-p.wtCLN1 revealed 113 palmitoylated
protein-encoding genes, corresponding to∼14% of the full DEGs
dataset in this cell line (Supplementary Table S4). Conversely,
a lower amount of DEGs coding for palmitoylated proteins
was identified in the two mutants (n = 38 for SH-p.L222P,
18% of DEGs; n = 36 in SH-p.M57Nfs∗45, 17% of DEGs;
Supplementary Tables S5, S6). Eighty-five genes coding for
palmitoylated proteins were specifically found in p.wtCLN1,
whereas only a small portion was selectively expressed in the
two mutants, (n = 9 in p.L222P and n = 15 in p.M57Nfs∗45).
Eight genes were common to all mutated cell lines (see Venn
diagram in Figure 4A and network analysis in Supplementary
Figure S4).
Bioinformatic categorization of 113 palmitoylated protein-
encoding genes seen in SH-p.wtCLN1 using PANTHER revealed
a significant enrichment in Cell Component GO terms related to
Neuron projection, Neurofilament, Growth cone, Axon as well as
Synapse (Supplementary Figure S5). Furthermore, 76 genes were
assigned to the main four, previously described IPA categories;
likewise, 25 genes were assigned to functional annotations related
to formation and elongation of neuronal processes, such as
neuritogenesis, branching of neurons and growth of neurites
(Table S7 in supplementary Materials). Confined collection
of these 25 genes, shared among relevant IPA functional
annotations and Cell Component GO terms, is outlined in
Figure 4B.
Gene-Product Expression of Selected
DEGs
Among DEGs coding for palmitoylated proteins detected in
SH-p.wtCLN1 cells, we selected genes relevant to elongation
of neuronal structures (GAP43, CRMP1 and NEFM) and
assessed their protein expression by WB. Immunoblotting
showed a decreased expression of the corresponding proteins
in cellular lysates of SH-p.wtCLN1, whereas no significant
changes in the other mutated CLN1 cell lines were observed
(Figure 5A). A similar trend was seen for the synaptic
marker SNAP25, another DEG specifically identified in
SH-p.wtCLN1. The quantification analysis in SH-p.wtCLN1 and
other cell lines (Figures 5B–E) confirmed a significant
down-regulation of these markers in SH-p.wtCLN1, and to
a lesser extent in SH-p.L222P cells. A reduced expression of
FIGURE 4 | Palmitoylation gene/protein survey. (A) Venn diagram of identified
palmitoylated gene products (palmitoylated proteins) among differentially
expressed genes in the transcriptomic profiles of SH-p.wtCLN1, SH-p.L222P
and SH-p.M57Nfs∗45, compared to an empty-vector (SH-pcDNA3)
expressing cells. The amount of identified DEGs is stated below the cell line
name, whereas the numbers of genes shared among the three comparisons
are reported in the intersections of the Venn diagram. Eighty-five of such
genes were selectively expressed in SH-p.wtCLN1 only. See Supplementary
Tables S4, S5, S6 for the compendium of genes of each CLN1 cell line and
Supplementary Figure S4 for genes assigned to each interaction area of Venn
diagram. (B) Twenty five genes, specifically expressed in SH-p.wtCLN1 cells,
were connected to Nervous System Development and Function as well as to
annotations related to neurites formations. Cell Component GO terms
(PANTHER) were also linked. Notably, CTSD, associated with CLN10 disease
was found to be up-regulated in wild-type PPT1-overexpressing cells, further
supporting a genetic interaction between these two neuronal ceroid
lipofuscinoses (NCL) genes. For an exhaustive compendium of identified
genes encoding the palmitoylated proteins and assigned IPA functions and
GO terms see Table S7 in supplementary materials. Genes, marked by a black
slash were further investigated for protein expression by Western Blotting (WB)
analysis.
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FIGURE 5 | Immunoblotting analysis of selected DEGs identified in SH p.wtCLN1 cells and encoding for palmitoylated proteins. (A) Representative WB of proteins
coded by four down-regulated genes (NF-M, CRMP1, GAP43 and SNAP25), identified in SH p.wtCLN1 transcriptomic profile. A strong decrease in protein
expression was evident in SH-p.wtCLN1 cellular lysates, in comparison to no visible effect in other cell lines. (B–E) Semi-quantitative WB analysis of the same
proteins confirmed highly decreased expression of these markers in SH-p.wtCLN1 cells, both under basal condition and following differentiation in RA-NBM medium.
A slight down-regulation in expression of a short 60 kDa isoform of CRMP1 (isoform 2), NF-M and SNAP25 following RA-NBM differentiation was detected in
SH-p.L222p lysates whereas no significant change in GAP43 expression was observed in the same cell line. GAPDH served as internal standard; a.u. arbitrary units;
mean ± SEM of three independent experiments; Two-way ANOVA followed by Bonferroni’s post-test; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
these proteins was already evident under basal conditions,
suggesting that down-regulation of these proteins (and
transcripts) is not related to the RA-NBM differentiation
process.
Impaired Neuritogenesis: Morphological
Features of CLN1 Transfected SH-SY5Y
Cells
Transcriptomic analysis and bioinformatic investigations
suggested a defective capacity of SH-p.wtCLN1 cells to
generate elongated cellular processes. We thus evaluated
the morphological changes undergoing in CLN1 transfected
cells during the differentiation process in RA-NBM medium.
Under basal conditions, all analyzed cells showed similar
morphological features and growth characteristics, except
those overexpressing wtCLN1, which exhibited a slow rate
of proliferation and a more flattened shape. Differentiation
in RA-NBM medium significantly stimulated the outgrowth
of neuronal processes in all cell lines (Supplementary Figure
S6). However, SH-p.wtCLN1 revealed a peculiar behavior:
cells shrank their cytoplasm, became more polarized and
extended some membrane processes during exposure to RA
medium for the first 6 days. At the same time, these cells
seemed to demonstrate a less triangular/branched shape in
comparison to the other cell lines. The exposure to NBM
medium enriched with neurotrophic factors for further
3 days increased the complexity and arborization of the
elongated structures in the different mutant cell lines and
controls, whereas wtCLN1 cells exhibited processes which
appeared more stunted and less arborized (Supplementary
Figure S6). Considering the predicted defect of neuritogenesis,
we subsequently tested the expression of β-III tubulin, a
cytoskeletal marker of neurites. Most of the arborized
neurites were heavily immunostained by β-III tubulin
antibody in differentiated SH-SY5Y, SH-pcDNA3 and SH-
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FIGURE 6 | Neurite growth features of CLN1 transfected cell lines following neuronal differentiation in RA-NBM medium. (A) Outgrowth of neurites in CLN1
transfected cells lines were evaluated by β-III tubulin immunostaining during neuronal differentiation. SH-p.wtCLN1 cells showed less arborized, stunted neurites in
comparison to mock-transfected cells and other CLN1 transfected cell lines. Nuclei are marked in blue; DIV, days in vitro; scale bars equal to 50 µm. For a qualitative
evaluation of cell morphology see also Figure S6 in the supplementary Materials. (B) The morphometric analysis of β-III tubulin immunolabeled processes pinpointed
a significant paucity of neurites longer than 30 µm in SH-p.wtCLN1 cells, in accordance with the bioinformatic findings. Likewise, a similar, even though not
significant, trend was seen for SH-p.L222P clone. Higher variability was detected in SH-p.M57Nfs∗45. These findings resembled the results about neurofilament
immunolabeled structures which are described in Figure S7 of supplementary Materials. Mean ± SEM of three independent experiments; One-way ANOVA followed
by Bonferroni’s post-test; ∗p < 0.05. (C) Immunoblotting analysis of β-III tubulin demonstrated a reduced expression of this cytoskeletal marker in
SH-p.wtCLN1 only, in accordance with the decreased number of neurites. Arrow pinpoints to a decreased expression of β-III tubulin in SH-p.wtCN1 cells.
(D) Semi-quantitative WB analysis confirmed a decreased expression of β-III tubulin in SH-p.wtCLN1, following differentiation in RA-NBM medium. GAPDH served as
internal standard; a.u. arbitrary units; mean ± SEM of three independent experiments; unpaired t-test; ∗p < 0.05.
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p.M57Nfs∗45 cells whereas fewer processes were detected
in SH-p.wtCLN1 following quantitative morphometric
evaluation (Figures 6A,B). Accordingly, we observed
a reduced expression of β-III tubulin in differentiated
SH-p.wtCLN1 (Figures 6C,D). Likewise, the immunofluorescent
analysis of pNF-H immunolabeled structures indicated that
SH-p.wtCLN1 cells (and to a lesser extent SH-p.L222P cells)
were characterized by less frequent axonal-like processes,
as compared to mutant and mock-transfected cells (see
Supplementary Material and Methods and Supplementary
Figure S7).
Synaptic Compartment-Related Genes in
SH-p.wtCLN1 Cells
Transcriptomic profiling and bioinformatic inquiry of DEGs
identified in SH-p.wtCLN1 put forward several functional
annotations related to synaptic compartment and synapse
function (Figure 3D). Therefore, we focused on four IPA
annotations related to neurotransmission (81 DEGs), namely
developmental process of synapse (z-score = −1.48), long-
term potentiation of synapse (z-score = −2.17), synaptic
transmission (z-score = −0.88) and neurotransmission
(z-score = 0.56; see Venn diagram in Figure 7A). Further
inquiry through GeneMANIA revealed close associations
between DEGs as far as genetic and physical interactions were
concerned (Figure 7B). Moreover, fold enrichment analysis
through PANTHER disclosed important functional relations
of those DEGs with synaptic and axonal compartments
(Cell Component GO terms of pre/post-synaptic membrane,
axon terminus and synaptic vesicle, Figure 7C) as well as
with regulatory activities of membrane channels (Molecular
Functions GO terms, Figure 7C). Specifically, various genes
were assigned to glutamate receptor activity (GRM1, GRM2,
GRM7, GRIN1), calcium channel regulator activity (GRM2,
NPY, GRM7, NRXN1) and voltage-gated cation channel activity
(KCNB1, OPRM1, KCNQ3, CACNA2D2, KCNK3, GRM7).
Among queried DEGs, 23 genes encoded palmitoylated
proteins (red nodes in Figure 7B and Supplementary
Table S4).
DISCUSSION
In this experimental setting, an increased expression of a
wild-type CLN1 was functionally linked to DEGs encoding
palmitoylated neuronal proteins, pinpointed impaired
cellular functions (i.e., neuritogenesis) and coupled with
dysregulated expression of synapse-related genes. Affected
modules and related functions are associated with the
pathological effects related to loss-of-function, and are
known to be affected in Ppt1−/− mice, including pathological
changes of a synaptic compartment (Virmani et al.,
2005; Kielar et al., 2009; Peng et al., 2015; Tikka et al.,
2016); moreover a severe epilepsy associated with typical
Electroencephalogram (EEG) pattern (Santavuori, 1973)
occurs in CLN1 patients, who are lacking PPT1 functional
activity.
The Effects of Transfection on
PPT1 Expression and Cellular
Differentiation
Characterization of the CLN1 transfected clones revealed
three patterns of expression (Table 1 and Figure 1). Despite
the successful transfection of CLN1 constructs, no enhanced
PPT1 signal was observed on immunoblots of SH-SY5Y cells
harboring the p.M57Nfs∗45 and p.G42_E78del mutations. It
is tempting to speculate that this finding was related to
the ablation of about two thirds (p.M57Nfs∗45), or excision
of 36 residues (p.G42_E78del) of a PPT1 protein, and a
likely degradation before post-translational processing is being
completed (Bravo et al., 2013). Alternatively, the deletion
may affect the conformation/folding properties of PPT1. In
accordance with both hypotheses, we could not measure the
PPT1 enzymatic activity above the endogenous level. Cells
harboring a missense mutation (p.L222P, p.V181L or p.V181M)
overexpressed a unique band migrating approximately at
∼41 kDa; a different electrophoretic pattern was also confirmed
upon de-glycosylation with PNGase as compared to the
de-glycosylated wtPPT1 isoform. The shift in the apparent
molecular weight may indicate a full-length PPT1, retaining the
N-term signal peptide (27 amino acids), which in turn may also
be hyper-glycosylated. It is not clear how these changes occur,
nor how they affect the catalytic domains of PPT1, as suggested
by lack of enzymatic activity observed for the overexpressed,
missense mutations bearing PPT1 proteoforms (Bellizzi et al.,
2000). Lastly, in SH-p.wtCLN1 overexpressing cells the two
glycosylated isoforms of mature PPT1 (38–36 kDa doublet,
mono- and di-glycosylated forms, respectively) could be detected
(Lyly et al., 2007; Scifo et al., 2015a). In accordance with the
pattern of expression on WB, a three-fold increase in EA was
observed (Figure 1D).
Normal processing of an overexpressed PPT1 in the SH-
p.wtCLN1 cells was suggested by IF where the identification
of PPT1 signal along axonal-like structures and in peripheral
regions (synaptic terminal and varicosities) of differentiated
cells was in accordance with outbound delivery of the protein,
similarly as described in other neuronal cell lines (Ahtiainen
et al., 2003). These patterns were not seen in missense clones
consistent with defective processing and mislocalization of
the mutated PPT1. Lastly, the used experimental conditions
did not affect the rate of cell death in any clone tested
(unpublished observations), in accordance with findings
previously described in LAN-5 neuroblastoma cell line (Cho and
Dawson, 2000).
RNA-seq Analyses
Our experimental findings indicated that the number of
DEGs was related to the amount of mutated CLN1 mRNA,
and to its’ ability to be translated into a functional protein.
These findings were supported by the number of identified
DEGs, which was similar among the two analyzed, mutated
cell lines (∼210 DEGs), but far less in comparison to the
overexpressing wtCLN1 clone (>800 DEGs). Bioinformatic
analysis of differentially expressed transcripts revealed
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FIGURE 7 | Bioinformatic survey of DEGs assigned to the synaptic compartment. (A) Four IPA functional annotations of SH-p.wtCLN1 transcriptomic profile, and
related to neuronal transmission were investigated. The number of DEGs assigned to each category is reported between brackets whereas the associated z-score is
reported below (green = predicted inhibition; red = predicted activation). The four IPA attributes enclosed 81 unique DEGs, which served as input for further
bioinformatic queries. (B) A functional network encompassing 81 DEGs drawn using GeneMANIA plugin in Cytoscape software. Both genetic and physical
interactions were used to denote the bridging nodes. Thick borders pinpoint DEGs which were specifically expressed in SH-p.wtCLN1, and not shared with the other
two mutants. Genes encoding for palmitoylated proteins are marked in red. GAP43 and BCAN nodes represent down-regulated genes of
SH-p.wtCLN1 transcriptomic profile. GAP43 encodes for a membrane protein associated with a growth cone of neuronal cells (see discussion section for further
information), whereas BCAN encodes brevican, a chondroitin sulfate proteoglycan highly expressed in the extracellular matrix of synaptic space (Blosa et al., 2015).
(C) Statistical overrepresentation profile of 81 DEGs derived through PANTHER classification system linked them to synaptic compartments as well as axons (Cell
Component GO terms categorization). Likewise, many genes were involved in membrane channel activity and regulation, as well as in neurotransmission and
glutamate receptor activity (Molecular Function GO terms). Fold Enrichment (FE) score represents a portion of genes enclosed in a specific term. Enrichment above a
score of 1 (marked by green line) indicates an overrepresentation. GO terms were grouped for related ontological classes and sorted hierarchically according to a
decreasing FE score, starting from the most specific subclass towards less specific ones. Only the most specific categories for each class associated with a FE
score greater than the expected value are shown. P-value was adjusted using Bonferroni correction for multiple testing and reported as −log10(p-value); red line
represents a p-value equal to 0.05.
functional links related to changes of neuronal cell shape
and formation of neurites, which were predicted to be impaired
in SH-p.wtCLN1; a similar trend (with less annotated functions)
was seen for SH-p.L222P. Accordingly, the morphometric
analysis pinpointed a reduced capacity of the same cell
lines, to generate primary axonal processes. Nonetheless,
the bioinformatic profiles of the two mutated clones were
different: the expression of the mutated protein (SH-p.L222P
clone) affected the expression of few genes which impacted
on the cell morphology, in partial overlap with SH-p.wtCLN1,
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whereas a markedly reduced number of annotations was
associated with the SH-p.M57Nfs∗45 clone, inept to yield any
functional PPT1 proteoform.
Functional annotations related to defective outgrowth of
neuronal structures (including neuritogenesis and sprouting) as
well as axonal degeneration have also been described in Ppt1−/−
mice at the pre-symptomatic stage (Tikka et al., 2016), and during
the early phase of embryonic neuronal development in a fly
model of CLN1 disease (Chu-Lagraff et al., 2010).
Moreover, a second meaningful functional module of SH-
p.wtCLN1 profile was related to the synaptic compartment and
synapse physiology annotations (Figures 3D, 7), and may be
consistent with the extra-lysosomal role of PPT1 in the nerve
terminals (Lehtovirta et al., 2001; Kim et al., 2008). A prospective
role of PPT1 in modulating the function of membrane proteins
related with neuronal excitability and, possibly, epileptogenesis
requires evidence gained by other experimental approaches.
Palmitoylation Gene Survey
We recognized 113 genes in SH-p.wtCLN1 dataset that
encoded palmitoylated proteins, of which 76 genes were
further assigned to relevant molecular and cellular functions
(Supplementary Table S4). Our results indicate that hyper-
depalmitoylating activity may perturb the expression of proteins
relevant to neuritogenesis and synaptic transmission. The precise
relationship underlying the apparent negative feedback between
an overexpressed depalmitoylating protein and genes encoding
palmitoylated proteins is not yet known. However, it has been
recently demonstrated that PPT1 itself is regulated by the
palmitoylation at cysteine residue in position 6 of the signal
peptide, creating a sort of a positive feedback loop (Segal-Salto
et al., 2016).
Twenty-five DEGs were of greater interest because they
encode palmitoylated proteins, assigned to both neuronal
branching and synaptic physiology. The downregulation
in wtCLN1 overexpressing cells of four proteins, namely
neuromodulin (GAP43), CRMP1, Neurofilament-M (NF-M)
and SNAP25, was corroborated by WB in both basal conditions
and following RA-NBM treatment. The role of GAP43,
CRMP1 and NFs in the elongation of cellular projections and
pathfinding processes have been extensively characterized
in neuronal cells. GAP43 localizes to the growth cones and
synaptic terminals of elongating axons and is mainly involved
in the modulation and arborization of growing neuronal
structures (Meiri et al., 1986; Benowitz and Routtenberg, 1997).
Both lipidation through palmitoylation and phosphorylation
regulate the localization and diffusion of GAP43 on the plasma
membrane, in the terminal tips of growing axons (Liu et al., 1994;
Strittmatter et al., 1994; Trenchi et al., 2009; Gauthier-Kemper
et al., 2014).
CRMP1, a member of the the Collapsin Response Mediator
Proteins (CRMPs) family, regulates many aspects of cytoskeletal
remodeling and arborization of neurites and dendrites in
neuronal cells (Yamashita and Goshima, 2012; Quach et al., 2015;
Nagai et al., 2017). Phosphorylation status of CRMP1 affects
the signaling pathways mediated by Semaphorin 3A (SEMA3A)
and reelin (Yamashita et al., 2006); notably, the latter was
an up-regulated gene in our wtPPT1 overexpressing cells (see
Figure 7). Interestingly, CRMP1 (as well as other palmitoylated
proteins) has been found dysregulated in Ppt1−/− mice (Tikka
et al., 2016; Segal-Salto et al., 2017), and it is an interacting
partner of PPT1 (Scifo et al., 2015a).
NFs provide the structural support for elongation and
stabilization of axonal processes during their maturation,
maintainance of cytoskeletal organization and control radial
axonal growth (Nixon and Shea, 1992; Lee and Cleveland, 1994;
Letourneau, 1996; Elder et al., 1999; Lariviere and Julien, 2004).
Down-regulation of mRNA encoding neurofilament proteins is
a common feature of human neurodegenerative diseases (Julien
and Mushynski, 1998), and mutated NF proteins can affect the
dynamics of other cytoskeletal components of the axons, leading
to fiber degeneration and neuronal death (Shea and Lee, 2013).
The reduced expression of GAP43, CRMP1 and both NF-H
andNF-M genes and proteins in SH-p.wtCLN1 cells may account
for the impaired axonal growth measured in our experimental
setting (Supplementary Figure S7). Changes in the expression
of genes encoding proteins of the synaptic compartment
(neurotransmitter receptors, ion channels, membrane proteins)
were also selectively found in SH-p.wtCLN1 (Figure 7). A
positive correlation was found for the downregulated expression
of SNAP25, a palmitoylated presynaptic protein, and of its
related gene, in SH-p.wtCLN1 cells. SNAP25 is a plasma
membrane protein of the pre-synaptic compartment, belonging
to the SNARE complex involved in the exocytosis machinery
(Wu et al., 2014). SNAP25 gene polymorphisms are associated
with ADHD, another neurodevelopmental disorder (Liu et al.,
2017).
Transcriptomic Profiling and NCL Genes
Cross-Talk
Cross-talk among NCL genes and proteins has been identified
and related to the pathogenesis of specific forms (Lyly et al.,
2009; Chandra et al., 2015). Our transcriptomic analyses revealed
up-regulation of mRNA CTSD in SH-wtCLN1 cells (see network
in Figure 4B). CTSD encodes a palmitoylated lysosomal enzyme
(Cathepsin D, CatD), involved in several biological processes
(Koch et al., 2013; Khalkhali-Ellis and Hendrix, 2014). Mutations
in CTSD are associated with congenital and infantile-onset NCL
(MIM #610127; Siintola et al., 2006; Doccini et al., 2016). The
processing of pro-CatD to mature CatD occurs in the lysosomal
compartment, but its maturation is disrupted in the Ppt1−/−
mice, possibly due to the elevated lysosomal pH (Chandra et al.,
2015; Bagh et al., 2017). Interestingly, CatD overexpression (both
at the transcript and protein level) is linked to murine Ppt1
knockout, though the cascade of events leading to enhanced
regulation is yet unknown. Furthermore, an overexpression of
PPT1 was recently detected in the brains of CLN4 patients, an
adult NCL caused by mutations in DnaJ Heat Shock Protein
Family (Hsp40) Member C5 (DNAJC5; MIM #162350; Nosková
et al., 2011). TheDNAJC5 gene encodes a palmitoylated cytosolic
protein (CSPα) associated with synaptic vesicles, possibly acting
as substrate of PPT1 (Mastrogiacomo et al., 1994; Henderson
et al., 2016). Mutations in the palmitoylated domain of CSPα
are associated with accumulation of aggregated PPT1 by still
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unknown mechanism(s), and possibly altered PPT1 activity
in different cell compartments (Henderson et al., 2016).
However, no differential expression of DNAJC5 mRNA was
found in our RNA-seq surveys. Nevertheless, the biochemical
link between the two diseases indicates that aberrant protein
palmitoylation is crucial for neuronal degeneration, affecting the
synaptic compartments in both conditions (Henderson et al.,
2016).
Concluding Remarks
The results of this study can be considered as the effect of
a likely altered gene dosage of wtCLN1 due to wild type
gene overexpression. Altered gene dosage is considered as a
molecular mechanism underpinning several human neurological
conditions determined by either deletion or duplication of the
same genetic traits (Lupski et al., 1991; Raskind et al., 1991;
Chance et al., 1993; Woodward et al., 1998; Margolis et al.,
2015). Although an overexpression and a loss-of-functionmodels
cannot be compared straightforwardly, our findings bring an
evidence on the effects of dysregulated networks of genes
coding for palmitoylated proteins in relation to the process
of axonal sprouting and proliferation in this CLN1/PPT1-
related experimental model. These findings are supported
by a recent study on the role of palmitoylation in axonal
dynamics (Holland and Thomas, 2017). An overexpression of
the depalmitoylating enzyme may unbalance the fine tuning
of the S-acylation process, thereby perturbing palmitoylated
membrane proteins, which in turn may impact the CLN1 disease
pathogenesis.
It is advised to consider that potential therapeutic strategies
(gene therapy, enzyme replacement or others) would likely be
more effective if they took into consideration the possible
dysregulation of genes (and proteins) downstream to
PPT1 (mal)function, including the disturbances in synaptic
palmitoylation networks. In approaches to therapy, however, it
is necessary to handle with caution the protein overexpression
since the locoregional enhancement of a lysosomal enzyme
may lead to cell stress, and hamper the predicted benefits of
the therapy (Migani et al., 2017). We thus recommend that
wide-range transcriptomic (as well as proteomic/metabolomics)
investigations with a focus on affected molecular functions
are carried out in animal models of genetic disorders prior
to human interventions, if complementation therapies are
considered as putative effective treatment of the underlying
condition.
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